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were an outlier for wound infection, then in the next year many
times, in fact almost all the time, we found centers moved back into
a more expected O/E ratio.
So my question to you is, did you have an opportunity to look
at this along the time, so that you could see whether or not some of
these effects actually go away? Which would be if somebody did
notice that their O/E ratio for the anesthesia was an outlier in
general anesthesia, I would predict that it would come back within
a normal O/E ratio, with people knowing that. So my question
is, have you done that? And if not, I think it would be a great
thing to do.
Dr Stoner. We did examine the use of anesthetic technique
over the study time period and did not see any trends. At this time,
I’m not aware if the NSQIP committee within the VA sector is
aware of this finding. We will make our findings available internally
first and then in our manuscript. But clearly that’s the mission and
the mechanism by which the NSQIP operates, which is a
continued evolution of care processes. And I think we’ve iden-
tified a significant care process which can be modified to im-
prove outcome.
Dr George Lavenson (Visalia, Calif). This information,
showing the lowest stroke and death rate currently obtainable with
carotid endarterectomy, is particularly important at this time when
new modalities, such as stenting, are being justified by comparison
with historical and overall surgical results instead of the best that
can be obtained with surgery. All are not the same: both Health
Grades and Money Magazine did note surgeons and institutions
with best results in carotid endarterectomy.
My question is regarding the exact technique and the specific
methods used during endarterectomy by those in your study with
the best results. We were included in Health Grades and Money
Magazine and have a less than 1% stroke/mortality rate. Our
method uses local anesthesia, and only 5% of the patients need a
shunt. Consequently, we are able to purposively keep our arteriot-
omy in the wider more proximal portion of the internal carotid
artery and free and remove the lesion with final cleaning with loop
magnification from within. This has the advantage of the eversion
technique but without the need to transect. There is less need of a
patch and less early postoperative thrombosis. I would appreciate
any information in your series regarding results as related to carotid
endarterectomy techniques.
Dr Stoner.Certainly it’s been the practice of our vascular unit
at the MGH [Massachusetts General Hospital] to employ selective
use of regional anesthetic selected by anatomic criteria and patient
criteria. And we agree with your statement.
However, within the NSQIP database we presented from
today, the resolution does not exist to answer that question. This
data, as sorted by CPT [Common Procedural Terminology] code,
contained essentially all carotid endarterectomies, regardless of
technique and shunt use, which again are not part of this database.
And maybe those questions can be answered as our society is now
rolling out a carotid database based on the NSQIP methodology,
and perhaps this more specialized version of the database will
answer those sort of questions.
unanswered.Dr Piergiorgio Cao (Perugia, Italy). Thank you very much
for providing very important information on the risk factors for
carotid endarterectomy.
I don’t know if I missed the information, but it seems that
coronary artery disease was not a predisposing risk factor for
complication. The presence of coronary disease is very important.
Were you able to grade the severity of coronary artery disease or to
analyze the subgroup with more severe disease predisposed to a
higher risk factor for surgery?
Dr Stoner. The short answer to your question is no. The
current version of the database that we presented today does not
have those data.
And the NSQIP database is a bit of a moving target. The
private sector version of the database, which is essentially the
next-generation version compared to what’s employed at the VA,
does stratify out risk factors such as prior coronary angioplasty and
stenting, history of angina, and history of coronary artery disease.
The data presented today from this 2000 to 2003 time period
include only the presence of congestive heart failure as a coronary
marker in the preop patients, and that’s a rather gross marker. So
those data do not exist in the current version of the database
presented today.
Dr Michael Golden (Philadelphia, Pa). I rise to merely com-
ment that I agree with the authors’ data that there is a benefit for
carotid endarterectomy patients from local/regional anesthesia
over general anesthesia. I also find that there is an additional
benefit from this that may not be reflected in your data. When
patients consider the options available to them for repair of their
carotid lesions, great emphasis has been placed on carotid artery
stenting. When carotid endarterectomy can be provided without a
general anesthetic and with no longer hospital stay than for stent-
ing, patients become much more receptive to the idea of surgery
rather than gravitating directly toward stenting alone.
Dr Stoner. That’s true. And I think that the assumption from
that is that by identifying that local regional anesthetic technique is
protective in our model, essentially we will be able to provide
carotid endarterectomy with a cardiac risk profile similar to what
we see in carotid angioplasty and stenting. And I think it’s very
important for surgeons to keep it in our armamentarium, as carotid
therapy is an evolving target. Carotid stenting seems to have
raised the bar a bit in terms of postoperative coronary compli-
cations, and surgery needs to be able to reach that bar to remain
the gold standard.
Dr Frank LoGerfo (Boston, Mass). To say that regional
anesthesia is protective is really going beyond your data. You don’t
know the fate of those patients who had regional anesthesia but
were converted to general anesthesia, because general anesthesia
trumps that in your data set. And as you point out in your own
institution, you use regional anesthesia selectively, depending on
the patient characteristics. So you can say there’s a difference in
your selective practice, but you cannot say regional anesthesia is
protective.
Dr Stoner.Within the confines of our multivariate model and
speaking purely from a statistical point of view, a general anesthetic
was an independent risk factor. But without the randomized
prospective trial, which is ongoing in the UK right now, it is
impossible to definitively state that, I agree.INVITED COMMENTARYTimothy F. Kresowik, MD, Iowa City, Iowa
After surviving earlier attacks on its efficacy through the
conduct of well-designed randomized trials, carotid end-
arterectomy (CEA) is again being challenged by the purported
“less-invasive” alternative of carotid artery stenting (CAS).
The study by Stoner et al provides important data for the
current debate but has limitations that leave many questionsThe SAPPHIRE trial injected the issue of cardiac morbidity
into the CEA vs CAS debate. Perioperative cardiac events can be
compared between studies only if similar, standardized protocols
are used for surveillance for myocardial damage. Unfortunately,
the National Surgical Quality Improvement Program database
includes only Q-wave myocardial infarction (a small subset of all
perioperative myocardial infarctions). However, the observation in
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better outcomes at least raises the question of whether the differ-
ences in cardiac morbidity seen in the SAPPHIRE trial were
anesthetic rather than procedure related.
An important issue often neglected in the CEA vs CAS debate
is whether neurologically asymptomatic, medically high-risk pa-
tients are likely to benefit from either procedure. The relatively
benign natural history of asymptomatic carotid stenosis established
in the Asymptomatic Carotid Atherosclerosis Study trial should
not be forgotten. The limitations of the National Surgical Quality
Improvement Program database with regard to the collection of
specific cardiac risk factors such as prior myocardial infarction or
the presence of angina limit the usefulness of this study in guiding
the selection of neurologically asymptomatic patients who are
more likely to benefit fromCEA.Many of the risk factors identifiedin this study (diabetes, age, and smoking) are surrogate markers for
coronary artery disease. A specific cardiac history combined with
noninvasive cardiac screening of selected individuals is likely a
more important risk assessment approach for the practicing sur-
geon than using the risk factors identified in this study alone.
Clinical studies like this one are as important as randomized
trials in establishing the efficacy of procedures. Community-wide
studies are necessary to demonstrate that the procedural outcomes
observed in a randomized trial can be achieved across the entire
spectrum of patients likely to undergo the procedure and physi-
cians likely to perform the procedure. This study adds to the
literature that supports the fact that CEA can be performed across
this spectrum with perioperative adverse event rates comparable to
those achieved in the randomized trials. It remains to be seen
whether this will be as true for CAS as it is for CEA.
